EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Longitudinal surveillance of antibiotic resistance and virulence evolution in Clostridioides difficile : a 4-year retrospective study of hospitalized patients in a tertiary hospital in China

Junjie Lao iD, Lingli Zhang, Xinghan Huang, Guangzhi Du, Wenjie Yang, Bangxing Lin, Shenghai Wu iD, Hongcan Zhao, Guoqian Xiang, Liqian Wang iD, Xianjun Wang iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.00494-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Junjie Lao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Clostridioides difficile, Anti-Bacterial Agents, Clostridium Infections, Drug Resistance, Bacterial. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clostridioides difficile ( C. difficile ) is the primary pathogen responsible for nosocomial infectious diarrhea and pseudomembranous colitis. In China, metronidazole and vancomycin are the preferred treatments for C. difficile infection (CDI). This study aimed to investigate the evolution of vancomycin (VA) and metronidazole (MTZ) resistance, as well as the longitudinal changes in virulence over time, using next-generation sequencing, drug susceptibility tests, and analysis of resistance and virulence genes. Additionally, we monitored the emergence of the highly virulent C. difficile strain RT027 and the spread and potential outbreak of C. difficile in the hospital setting. A random stratified sampling method was used to select 114 fecal samples from inpatients at Affiliated Hangzhou First People’s Hospital, School of Medicine, Westlake University, between 2021 and 2024. Clinical data from the enrolled patients were also collected. We conducted antigen and toxin protein detection for C. difficile , strain isolation and identification, drug sensitivity tests, whole genome sequencing, and bioinformatics analysis. This included comparisons of drug resistance genes, detection of toxin genes, and the construction of phylogenetic trees based on pan-genome analysis to investigate the resistance and toxin gene variations in C. difficile . Among the 114 samples collected from Affiliated Hangzhou First People’s Hospital, School of Medicine, Westlake University, no vancomycin- or metronidazole-resistant strains were identified. However, the average minimum inhibitory concentration (MIC) of C. difficile to vancomycin increased annually ( H = 33.208, P < 0.05). The average MIC of C. difficile to metronidazole was highest in 2022 but decreased in 2023 and 2024 ( H = 41.990, P < 0.05). Notably, in 2024, one C. difficile strain exhibited an MIC for metronidazole at the resistance threshold (2.00 μg/mL). Further Spearman correlation analysis of the strain years with drug sensitivity results revealed a positive correlation between strain years and the MIC levels of vancomycin and metronidazole ( r = 0.528, P < 0.05; r = 0.377, P < 0.05). The proportion of toxin-producing strains increased annually, with 100% of strains in 2024 producing toxins, representing the highest proportion compared to the previous three years ( X ² =11.75, P < 0.05). Both vancomycin and metronidazole remain effective for the treatment of CDI in clinical practice. However, the sensitivity of C. difficile to these two drugs is gradually decreasing, and the rate of toxin gene carriage is also rising in clinical cases. No hospital outbreaks of C. difficile infections were identified in this study. IMPORTANCE Clostridioides difficile has developed resistance to multiple antibiotics, including cephalosporins, clindamycin, and fluoroquinolones. This has exacerbated the global antibiotic resistance crisis. In China, according to current treatment guidelines, vancomycin and metronidazole are the preferred first-line drugs for treating C. difficile infections. However, there are reports indicating the emergence of new resistance to both vancomycin and metronidazole. Although there is extensive research on the long-term antibiotic resistance of C. difficile abroad, research on the continuous monitoring of antibiotic resistance and potential outbreaks of C. difficile in China is relatively limited. To fill this gap, we studied positive C. difficile strains from a tertiary general hospital in China. Through Next-Generation Sequencing (NGS), drug sensitivity testing, and analysis of drug resistance and virulence genes, we revealed the evolution of C. difficile's resistance to vancomycin and metronidazole, as well as changes in virulence, and monitored the spread within the hospital and potential outbreaks of C. difficile .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridioides difficileAnti-Bacterial AgentsClostridium InfectionsDrug Resistance, BacterialHumansChinaVancomycinMetronidazoleRetrospective StudiesLongitudinal StudiesMicrobial Sensitivity TestsTertiary Care CentersVirulenceFemaleMaleAgedPhylogenyFecesAdultCross InfectionVirulence Factors

Stichwörter der Autor:innen

C. difficile virulence genesClostridioides difficileantibiotic resistancemetronidazolevancomycin

Substanzen

Anti-Bacterial AgentsVancomycinMetronidazoleVirulence Factors

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, China.
  • The Fourth School of Clinical Medicine, Hangzhou First People's Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • The First Affiliated Hospital, Zhejiang University School of Medicine, Liangzhu Branch, Hangzhou, Zhejiang, China.

ORCID-Profile: Junjie Lao, Shenghai Wu, Liqian Wang, Xianjun Wang

Zitieren

APA

Lao, J., Zhang, L., Huang, X., Du, G., Yang, W., Lin, B., Wu, S., Zhao, H., Xiang, G., Wang, L., & Wang, X. (2026). Longitudinal surveillance of antibiotic resistance and virulence evolution in Clostridioides difficile : a 4-year retrospective study of hospitalized patients in a tertiary hospital in China. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00494-26

Vancouver

Lao J, Zhang L, Huang X, Du G, Yang W, Lin B, et al. Longitudinal surveillance of antibiotic resistance and virulence evolution in Clostridioides difficile : a 4-year retrospective study of hospitalized patients in a tertiary hospital in China. Microbiology Spectrum. 2026. doi:10.1128/spectrum.00494-26

BibTeX
@article{Lao2026,
  author = {Lao, Junjie and Zhang, Lingli and Huang, Xinghan and Du, Guangzhi and Yang, Wenjie and Lin, Bangxing and Wu, Shenghai and Zhao, Hongcan and Xiang, Guoqian and Wang, Liqian and Wang, Xianjun},
  title = {Longitudinal surveillance of antibiotic resistance and virulence evolution in Clostridioides difficile : a 4-year retrospective study of hospitalized patients in a tertiary hospital in China},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.00494-26}
}
Kostenlos starten →